LGND

Ligand Pharmaceuticals Incorporated News Headlines

$53.7
*  
0.29
0.54%
Get LGND Alerts
*Delayed - data as of Nov. 26, 2014  -  Find a broker to begin trading LGND now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    LGND Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Will BioMarin (BMRN) Disappoint This Earnings Season? - Analyst Blog
10/21/2014 4:30:00 PM - Zacks.com


Will Alexion (ALXN) Earnings Suffer Due to Higher Costs? - Analyst Blog
10/21/2014 4:05:00 PM - Zacks.com


Celgene (CELG) Q3 Earnings to Be Overrun by Expenses? - Analyst Blog
10/21/2014 3:50:00 PM - Zacks.com


Why Ligand Pharmaceuticals (LGND) Isn't Done Growing Earnings Yet - Tale of the Tape
10/21/2014 7:48:00 AM - Zacks.com


Will GlaxoSmithKline (GSK) Earnings Suffer on China Probe? - Analyst Blog
10/20/2014 5:15:00 PM - Zacks.com


Will Biogen Idec (BIIB) Pull a Surprise this Earnings Season? - Analyst Blog
10/20/2014 3:45:00 PM - Zacks.com


Will Abbott Labs (ABT) Miss on Earnings This Quarter? - Analyst Blog
10/20/2014 3:35:00 PM - Zacks.com


Will Sangamo (SGMO) Incur Wider-than-Expected Q3 Loss? - Analyst Blog
10/20/2014 11:50:00 AM - Zacks.com


Fr. Emmanuel Lemelson On Recent Sell-Off In Equity Markets, Amvona Fund's Long And Short Positions
10/18/2014 10:12:00 AM - Seeking Alpha


Ultragenyx Reports Data from Sialic Acid Deficiency Study - Analyst Blog
10/17/2014 4:00:00 PM - Zacks.com


Intra-Cellular Therapies Reveals Top-line Data on ITI-007 - Analyst Blog
10/16/2014 4:50:00 PM - Zacks.com


Tekmira Presents Data on Hepatitis B Candidate TKM-HBV - Analyst Blog
10/16/2014 4:30:00 PM - Zacks.com


Alexion (ALXN) Seeks Japanese Approval for Asfotase Alfa - Analyst Blog
10/16/2014 3:30:00 PM - Zacks.com


Can Illumina (ILMN) Keep the Earnings Streak Alive in Q3? - Analyst Blog
10/16/2014 12:50:00 PM - Zacks.com


Orexigen Up on $100M Milestone Payment from Takeda - Analyst Blog
10/16/2014 12:37:00 PM - Zacks.com


MannKind (MNKD) Worth Watching: Stock Gains 12.9% - Tale of the Tape
10/16/2014 8:46:00 AM - Zacks.com


InsiderInsights.com Daily Round Up 10/15/14: LGND, RKUS, NRP, IVAC
10/16/2014 8:31:00 AM - Seeking Alpha


GW Pharmaceuticals Down on Disappointing Mid-Stage Data - Analyst Blog
10/15/2014 5:48:00 PM - Zacks.com


Mallinckrodt Gives FY15 Guidance Post Questcor Acquisition - Analyst Blog
10/15/2014 4:10:00 PM - Zacks.com


AbbVie Reconsiders Shire Acquisition Due to New Tax Rules - Analyst Blog
10/15/2014 4:00:00 PM - Zacks.com


Alnylam Reveals Positive Data from its Pipeline Candidates - Analyst Blog
10/15/2014 3:30:00 PM - Zacks.com


Will Ligand Pharmaceuticals (LGND) Crush Estimates at Its Next Earnings Report? - Tale of the Tape
10/15/2014 7:47:00 AM - Zacks.com


Cyclacel Provides SEAMLESS Study Update on Sapacitabine - Analyst Blog
10/14/2014 5:25:00 PM - Zacks.com


AbbVie's Humira Positive in Late-Stage Skin Disease Study - Analyst Blog
10/14/2014 5:05:00 PM - Zacks.com


Pfizer's Breast Cancer Candidate Gets Priority Review - Analyst Blog
10/14/2014 5:00:00 PM - Zacks.com